Dworsky Alan J 13D/13G Filings for Enanta Pharmaceuticals, Inc. (ENTA)

Dworsky Alan J 13D and 13G filings for Enanta Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-04
4:08 pm
Sale
2021-12-31 13G Enanta Pharmaceuticals, Inc.
ENTA
Dworsky Alan J 114,496
1.000%
-1,092,915decrease
(-90.52%)
Filing
2021-01-28
08:40 am
Sale
2020-12-31 13G Enanta Pharmaceuticals, Inc.
ENTA
Dworsky Alan J 1,207,411
6.000%
-2,362decrease
(-0.20%)
Filing